Document is current
Any future updates will be listed below
-
Authors
Calonaci, Nicola https://orcid.org/0000-0003-2721-4888
Krasniqi, Eriseld https://orcid.org/0000-0002-6702-0087
Colic, Daniel
Scalera, Stefano
Gandolfi, Giorgia
Milite, Salvatore https://orcid.org/0000-0002-0156-3636
Bräutigam, Konstantin https://orcid.org/0000-0002-3966-3579
Sottoriva, Andrea https://orcid.org/0000-0001-6709-9533
Graham, Trevor A. https://orcid.org/0000-0001-9582-1597
Egidi, Leonardo
Ricciuti, Biagio
Maugeri-Saccà, Marcello
Caravagna, Giulio https://orcid.org/0000-0003-4240-3265
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (32107)
Fondazione IRCCS Regina Elena National Cancer Institute’s “Ricerca Corrente” granted by the Italian Ministry of Health
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P500PM_217647/1)
- License Information
-
More Information
Article History
Received: 16 May 2024
Accepted: 5 June 2026
First Online: 31 July 2026
Ethics
Competing interests: T.G. is named as a coinventor on patent applications that describe a method for T cell receptor sequencing (GB2305655.9), a method to measure evolutionary dynamics in cancers using DNA methylation (GB2317139.0) and a method to infer drug resistance mechanisms from barcoding data (GB2501439.0). T.G. has received consultancy fees from DAiNA therapeutics. The other authors declare no competing interests.
